Analytical Data
-
Gene name
DIDO1
- Application
-
Alternative Names
BYE1; DATF1; DIDO2; DIDO3; DIO1; Death Associated Transcription Factor 1
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9BTC0
-
Expression Region
Lys258~Cys455
-
Molecular Weight
31kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
DIDO1, or Dido homolog 1, is a protein associated with various cellular processes, including apoptosis, cell differentiation, and immune responses. Recent studies have indicated that DIDO1 may play a significant role in the pathogenesis of several diseases, including cancer and neurodegenerative disorders, due to its involvement in regulating gene expression and cellular signaling pathways. The recombinant expression of DIDO1 allows researchers to produce large quantities of this protein for detailed functional studies and therapeutic investigations. Understanding its structure and function in a controlled environment is crucial for elucidating its mechanisms in disease and identifying potential targets for drug development. Recent advances in recombinant DNA technology have facilitated the efficient production of DIDO1, enabling scientists to explore its biochemical properties, interaction partners, and regulatory roles within the cell. Furthermore, the generation of recombinant DIDO1 offers a valuable tool for high-throughput screening assays, potentially leading to novel therapeutic strategies aimed at modulating its activity in disease contexts. Overall, the study of DIDO1 recombinant protein is essential for uncovering its biological significance and therapeutic potential, opening avenues for future research and clinical applications.
